Medically reviewed by Drugs.com. Last updated on Apr 8, 2021.
The recommended dosage for TIGLUTIK is 50 mg (10 mL) taken orally or via Percutaneous Endoscopic Gastrostomy tubes (PEG-tubes) twice daily, every 12 hours. TIGLUTIK should be taken at least 1 hour before or 2 hours after a meal [see Clinical Pharmacology (12.3)].
Monitoring to Assess Safety
Measure serum aminotransferases before and during treatment with TIGLUTIK [see Warnings and Precautions (5.1)].
Important Administration Instructions
Gently shake the TIGLUTIK bottle for at least 30 seconds before administration.Gently shake the TIGLUTIK bottle for at least 30 seconds before administration.
TIGLUTIK can be administered by mouth or via percutaneous endoscopic gastrostomy tubes (PEG-tubes). Both silicone and polyurethane PEG tubes can be used.
See the Instructions for Use for further administration details.See the Instructions for Use for further administration details.
Frequently asked questions
More about Tiglutik (riluzole)
- Side effects
- Drug interactions
- During pregnancy or Breastfeeding
- En español
- Drug class: miscellaneous central nervous system agents
- FDA approval history
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.